CAROLINA GAYMON: Open Payments
NPI 1588202758 · FLORENCE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,574 in 72 payments from 14 companies in 2025. Trend: 2023 $1,276 · 2024 $3,378 · 2025 $1,574
Food & beverage: $1,574
| Company | Payments | Amount |
|---|---|---|
| SANOFI-AVENTIS U.S. LLC | 9 | $224 |
| ABBVIE INC. | 8 | $170 |
| Insulet Corporation | 6 | $163 |
| TOLMAR, INC. | 10 | $160 |
| Lilly USA, LLC | 7 | $140 |
| PFIZER INC. | 5 | $122 |
| Novo Nordisk Inc | 6 | $118 |
| Abbott Laboratories | 6 | $118 |
| Ascendis Pharma Endocrinology Inc | 4 | $89 |
| BETA BIONICS, INC. | 4 | $82 |
Products named: TZIELD, LUPRON DEPOT, Omnipod, FENSOLVI, JARDIANCE, FREESTYLE LIBRE 3, GENOTROPIN, Skytrofa.
Industry payments across SC — which companies pay providers there.
